Kisspeptin

Published Kisspeptin-10 human research has used weight-based intravenous study designs rather than standardized commercial dosing. In one dose-response study in healthy men, intravenous bolus doses of 0.01, 0.03, 0.1, 0.3, 1.0, and 3.0 micrograms per kilogram were studied, with the strongest LH response observed around 1.0 microgram per kilogram in that protocol. Continuous infusion models have also been studied at microgram-per-kilogram-per-hour rates. These figures should be understood as clinical-study context only and should not be presented as personal dosing instructions.

Researcher-reported exploratory Kisspeptin-10 ranges commonly discuss fixed amounts around 100-200 micrograms per exposure, often studied once daily or several times weekly depending on the model, with some educational protocols discussing gradual titration and cycle-based windows. These researcher-reported ranges are not the same as validated dosing standards. Protocol design depends on the study model, route, concentration, hormone markers being monitored, exposure frequency, and intended reproductive-axis endpoint.

For storage and handling, keep unopened lyophilized vials refrigerated when possible, protected from direct light, heat, and repeated temperature changes. Once reconstituted, keep refrigerated and avoid unnecessary warming, freezing, or repeated agitation. If mixing is needed after adding diluent, gently swirl the vial rather than shaking it.